Login to Your Account

Pharma: Other News To Note

Thursday, March 22, 2012

• Watson Pharmaceuticals Inc., of Parsippany, N.J., said its subsidiary Watson Laboratories Inc. received approval from the FDA for its abbreviated new drug application for ibandronate 150-mg tablets, a generic equivalent to Boniva (Roche AG).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription